UK markets closed

180 Life Sciences Corp. (ATNF)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.8000-0.1000 (-5.26%)
As of 11:33AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
3,818
2,785
2,433
3,948
2,293
Selling general and administrative
12,902
10,693
15,465
11,693
3,355
Total operating expenses
16,720
13,478
17,898
15,641
5,648
Operating income or loss
-16,720
-13,477
-17,898
-15,641
-5,648
Interest expense
35.412
44.828
28.175
186.208
1,087
Total other income/expenses net
799.66
-8,762
-21,744
-4,521
-4,169
Income before tax
-15,954
-22,285
-39,669
-20,348
-10,904
Income tax expense
-6.617
-2,349
-942.749
-23.204
-20.427
Income from continuing operations
-15,948
-19,935
-38,726
-20,325
-10,884
Net income
-15,948
-19,935
-38,726
-20,325
-10,884
Net income available to common shareholders
-15,948
-19,935
-38,726
-20,325
-12,007
Basic EPS
-14.20
-
-387.18
-246.24
-250.80
Diluted EPS
-14.20
-
-387.18
-246.24
-250.80
Basic average shares
4,802
-
100.02
82.514
47.773
Diluted average shares
4,802
-
100.02
82.514
47.773